Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers.
Dannehl D, Engler T, Volmer LL, Tegeler CM, Fusshoeller J, Gabrysch E, Eissler K, Seller A, Grischke EM, Hahn M, Gruber I, Schochter F, Pfister K, Veselinovic K, Leinert E, Rack B, Fink V, Janni W, Brucker SY, Hartkopf AD, Schäffler H.
Dannehl D, et al. Among authors: hahn m.
Cancers (Basel). 2023 Jul 28;15(15):3847. doi: 10.3390/cancers15153847.
Cancers (Basel). 2023.
PMID: 37568663
Free PMC article.